Red cell distribution width: An inexpensive and powerful prognostic marker in heart failure

European Journal of Heart Failure

Volumn 11, Issue 12, 2009, Pages 1155-1162

  Al Najjar, Yahya ^a   Goode, Kevin M ^a   Zhang, Jufen ^a   Cleland, John G F ^a   Clark, Andrew L ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Heart failure; Markers; NT proBNP; Prognosis; Red cell distribution width

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ERYTHROCYTE; ERYTHROCYTE VOLUME; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

AGED; ERYTHROCYTE VOLUME; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; SURVIVAL RATE;

EID: 72949091248     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp147     Document Type: Article

References (29)

1. Tatsumi E, Nakatani T, Imachi K, Umezu M, Kyo SE, Sase K, Takatani S, Matsuda H. Domestic and foreign trends in the prevalence of heart failure and the necessity of next-generation artificial hearts: a survey by the Working Group on Establishment of Assessment Guidelines for Next-Generation Artificial Heart Systems. J Artif Organs 2007;10:187-194. Epub ahead of print 20 December 2007.
2. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka JM, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402. (Pubitemid 35239711)
3. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. J Am Med Assoc 2004;292:344-350.
4. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-wilson PA, Sutton GC. Survival of patients with a new diagnosis of heart failure: a population-based study. Heart 2000;83:505-510.
5. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-322.
6. Ko DT, Alter DA, Austin PC, You JJ, Lee DS, Qui F, Stukel TA, Tu JV. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J 2008;155:324-331.
7. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Br Med J 2005;330:625.
8. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-356.
9. Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN, Val-HeFT Investigators. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 2008;52:997-1003.
10. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743.
11. Moe GW. B-type natriuretic peptide in heart failure. Curr Opin Cardiol 2006;21: 208-214.
12. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure. J Am Coll Cardiol 2007;50:40-47. Epub ahead of print 18 June 2007.
13. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991; 9(Suppl. 1):71-74.
14. Marsh WL, Bishop JW, Darey TP. Evaluation of red cell volume distribution width (RDW). Haematol Pathol 1987;1:117-123.
15. Bessman JD, Gilmer PR Jr, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983;80:322-326.
16. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-168. Epub ahead of print 2 January 2008.
17. Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 2009; [Epub ahead of print 12 January 2009].
18. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 2009;277:103-108. Epub ahead of print 22 November 2008.
19. Spell DW, Jones DV Jr, Harper WF, David Bessman J. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev 2004;28:37-42.
20. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion Mar 2005;20:83-90.
21. Chiari MM, Bagnoli R, De Luca PD, Monti M, Rampoldi E, Cunietti E. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc 1995;43:767-771.
22. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira MM, Hellewell PG, Hooper J, Poole-Wilson PA, Coats AJ. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-693.
23. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J 2000;21: 521-532.
24. Deswal A, Peterson MJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database form the Vesnarinone Trial (VEST). Circulation 2001;103:2055-2059. (Pubitemid 32373007)
25. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-2667.
26. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433. Epub ahead of print 13 March 2006.
27. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934-1941.
28. Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, Erdmann E, Schneider CA. Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients. Eur J Heart Fail 2008;10:315-320. Epub ahead of print 4 March 2008.
29. Van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 2004;44:63-67.